Treatment decisions and contemporary versus pending treatments for hepatitis C
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment decisions and contemporary versus pending treatments for hepatitis C
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume 10, Issue 12, Pages 713-728
Publisher
Springer Nature
Online
2013-09-10
DOI
10.1038/nrgastro.2013.163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts
- (2013) Priya Duggal et al. ANNALS OF INTERNAL MEDICINE
- A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care
- (2013) Christopher E. McGowan et al. HEPATOLOGY
- 1423 INTERIM ANALYSIS OF AN INTERFERON (IFN)- AND RIBAVIRIN (RBV)-FREE REGIMEN OF DACLATASVIR (DCV), ASUNAPREVIR (ASV), AND BMS-791325 IN TREATMENT-NAIVE, HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS
- (2013) G.T. Everson et al. JOURNAL OF HEPATOLOGY
- 66 HIGH SUSTAINED VIRAL RESPONSE AT 12- AND 24-WEEK FOLLOW-UP OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) IN HCV GENOTYPE 1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS
- (2013) M. Manns et al. JOURNAL OF HEPATOLOGY
- 67 TELAPREVIR WITH ADJUSTED DOSE OF RIBAVIRIN IN NAIVE CHC-G1: EFFICACY AND TREATMENT IN CHC IN HEMODIALYSIS POPULATION. TARGET C (RCT)
- (2013) P.P. Basu et al. JOURNAL OF HEPATOLOGY
- 14 ALL-ORAL SOFOSBUVIR-BASED 12-WEEK REGIMENS FOR THE TREATMENT OF CHRONIC HCV INFECTION: THE ELECTRON STUDY
- (2013) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- 64 GS-5885 + GS-9451 + PEGINTERFERON AND RIBAVIRIN (PR) FOR SIX OR TWELVE WEEKS ACHIEVES HIGH SVR12 RATES IN TREATMENT-NAÏVE GENOTYPE 1 IL28B CC PATIENTS
- (2013) A. Thompson et al. JOURNAL OF HEPATOLOGY
- 881 HIGH SVR RATES (SVR4) FOR 12-WEEK TOTAL TELAPREVIR COMBINATION THERAPY IN IL28B CC TREATMENT-NAÏVES AND PRIOR RELAPSERS WITH G1 CHRONIC HEPATITIS C: CONCISE INTERIM ANALYSIS
- (2013) D.R. Nelson et al. JOURNAL OF HEPATOLOGY
- 60 SVR12 RATES AND SAFETY OF TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR IN 221 CIRRHOTIC NON RESPONDERS TREATED IN THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)
- (2013) H. Fontaine et al. JOURNAL OF HEPATOLOGY
- 3 SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/− RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY
- (2013) K.V. Kowdley et al. JOURNAL OF HEPATOLOGY
- 1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)
- (2013) M.S. Sulkowski et al. JOURNAL OF HEPATOLOGY
- 1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL
- (2013) M. Manns et al. JOURNAL OF HEPATOLOGY
- 1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL
- (2013) I. Jacobson et al. JOURNAL OF HEPATOLOGY
- 1416 FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAÏVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL
- (2013) P. Ferenci et al. JOURNAL OF HEPATOLOGY
- Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3
- (2013) Marcelo O. Silva et al. JOURNAL OF HEPATOLOGY
- Current Management of Hepatitis C Virus Infection in Patients With HIV Co-infection
- (2013) M. S. Sulkowski JOURNAL OF INFECTIOUS DISEASES
- Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: Meta-analysis of clinical studies
- (2013) Fabrizio Fabrizi et al. JOURNAL OF MEDICAL VIROLOGY
- Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
- (2013) Kris V Kowdley et al. LANCET
- Boceprevir for HCV in patients with HIV: where next?
- (2013) Anuoluwapo Osinusi et al. LANCET INFECTIOUS DISEASES
- Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial
- (2013) Katja Deterding et al. LANCET INFECTIOUS DISEASES
- Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial
- (2013) Mark Sulkowski et al. LANCET INFECTIOUS DISEASES
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
- (2013) Eric Lawitz et al. LANCET INFECTIOUS DISEASES
- How to optimize HCV therapy in genotype 1 patients with cirrhosis
- (2013) Marc Bourlière et al. LIVER INTERNATIONAL
- Current management and perspectives for HCV recurrence after liver transplantation
- (2013) Audrey Coilly et al. LIVER INTERNATIONAL
- Interferon free therapy with direct acting antivirals for HCV
- (2013) Tarik Asselah et al. LIVER INTERNATIONAL
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Faldaprevir and Deleobuvir for HCV Genotype 1 Infection
- (2013) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
- (2013) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on HIV/HCV Coinfection
- (2013) Vincent Soriano et al. Current HIV/AIDS Reports
- Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients
- (2012) J. Schreiber et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Triple therapy with boceprevir or telaprevir for prior HCV non-responders
- (2012) Tarik Asselah BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Hepatitis C Virus Infection and Mixed Cryoglobulinemia
- (2012) Gianfranco Lauletta et al. Clinical & Developmental Immunology
- Update on the Treatment of Patients With Non–Genotype 1 Hepatitis C Virus Infection
- (2012) Alessandra Mangia et al. CLINICAL INFECTIOUS DISEASES
- Acoustic Radiation Force Impulse Elastography for fibrosis evaluation in patients with chronic hepatitis C: An international multicenter study
- (2012) Ioan Sporea et al. EUROPEAN JOURNAL OF RADIOLOGY
- Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C
- (2012) Laurent Castera GASTROENTEROLOGY
- Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
- (2012) Calogero Cammà et al. HEPATOLOGY
- Informed deferral: A moral requirement for entry into the hepatitis C virus treatment warehouse
- (2012) Andrew Aronsohn et al. HEPATOLOGY
- Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers
- (2012) Ellen Hulskotte et al. HEPATOLOGY
- Review and management of drug interactions with boceprevir and telaprevir
- (2012) Jennifer J. Kiser et al. HEPATOLOGY
- Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin
- (2012) Ira M. Jacobson et al. HEPATOLOGY
- Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial
- (2012) Maribel Rodriguez-Torres et al. HIV CLINICAL TRIALS
- Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population
- (2012) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- 12 HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR AND GS-9256 WITH PEGINTERFERON-ALFA 2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS
- (2012) D.R. Nelson et al. JOURNAL OF HEPATOLOGY
- Favorable association between genetic polymorphisms near the IL28B gene and hepatic steatosis: Direct or indirect?
- (2012) Hidenori Toyoda et al. JOURNAL OF HEPATOLOGY
- Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: A model-based analysis
- (2012) Sylvie Deuffic-Burban et al. JOURNAL OF HEPATOLOGY
- Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2–6: TMC435-C202, a phase IIa, open-label study
- (2012) Christophe Moreno et al. JOURNAL OF HEPATOLOGY
- Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
- (2012) Martin Schaefer et al. JOURNAL OF HEPATOLOGY
- Clinical management of drug–drug interactions in HCV therapy: Challenges and solutions
- (2012) David Burger et al. JOURNAL OF HEPATOLOGY
- Virologic response and characterisation of HCV genotype 2–6 in patients receiving TMC435 monotherapy (study TMC435-C202)
- (2012) Oliver Lenz et al. JOURNAL OF HEPATOLOGY
- How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
- (2012) G. Sebastiani et al. JOURNAL OF VIRAL HEPATITIS
- Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
- (2012) Stanislas Pol et al. LANCET INFECTIOUS DISEASES
- Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation
- (2012) Robert J. Fontana et al. LIVER TRANSPLANTATION
- Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
- (2012) Margaret E Hellard et al. MEDICAL JOURNAL OF AUSTRALIA
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Magnetic Resonance Elastography for Staging Liver Fibrosis in Chronic Hepatitis C
- (2012) Shintaro ICHIKAWA et al. Magnetic Resonance in Medical Sciences
- A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C
- (2011) Jérôme Boursier et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Response to antiviral therapy in patients with genotype 3 chronic hepatitis C
- (2011) Dania Shoeb et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C
- (2011) Julien Vergniol et al. GASTROENTEROLOGY
- Differential Efficacy of Protease Inhibitors Against HCV Genotypes 2a, 3a, 5a, and 6a NS3/4A Protease Recombinant Viruses
- (2011) Judith M. Gottwein et al. GASTROENTEROLOGY
- Human immunodeficiency virus and liver disease forum 2010: Conference proceedings
- (2011) Kenneth E. Sherman et al. HEPATOLOGY
- Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus
- (2011) Varun Garg et al. HEPATOLOGY
- Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
- (2011) Natasha K. Martin et al. HEPATOLOGY
- Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
- (2011) Kazuaki Chayama et al. HEPATOLOGY
- Non-invasive assessment of liver fibrosis in chronic hepatitis C
- (2011) Laurent Castera Hepatology International
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals
- (2011) Patrice Cacoub et al. JOURNAL OF HEPATOLOGY
- Non invasive evaluation of portal hypertension using transient elastography
- (2011) Laurent Castera et al. JOURNAL OF HEPATOLOGY
- Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection
- (2011) H. Jafferbhoy et al. JOURNAL OF VIRAL HEPATITIS
- Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b
- (2011) J. Vermehren et al. JOURNAL OF VIRAL HEPATITIS
- Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin
- (2011) Paul Y. Kwo LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients
- (2011) Krista J. M. Stibbe et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Treatment of chronic hepatitis C in elderly patients
- (2010) Y Horsmans EXPERT OPINION ON PHARMACOTHERAPY
- Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C
- (2010) Takasuke Fukuhara et al. GASTROENTEROLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
- (2010) J. Parkes et al. GUT
- Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study
- (2010) Savino Bruno et al. HEPATOLOGY
- Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection
- (2010) Michael R. Charlton et al. HEPATOLOGY
- Hepatitis C and Depressive Symptoms: Psychological and Social Factors Matter More Than Liver Injury
- (2010) Michael P. Wilson et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
- Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update
- (2010) S. Sockalingam et al. JOURNAL OF VIRAL HEPATITIS
- Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C
- (2010) J. Parkes et al. JOURNAL OF VIRAL HEPATITIS
- Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
- (2010) Paul Y Kwo et al. LANCET
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients
- (2009) A. IACOBELLIS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Validation of Hepascore, Compared With Simple Indices of Fibrosis, in Patients With Chronic Hepatitis C Virus Infection in United States
- (2009) Laren Becker et al. Clinical Gastroenterology and Hepatology
- Tailoring the length of antiviral treatment for hepatitis C
- (2009) A. Mangia et al. GUT
- Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
- (2009) Simone Susser et al. HEPATOLOGY
- The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
- (2009) Nabil Antaki et al. LIVER INTERNATIONAL
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiviral Treatment of Recurrent Hepatitis C After Liver Transplantation: Predictors of Response and Long-Term Outcome
- (2009) Nazia Selzner et al. TRANSPLANTATION
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
- (2008) Marina Berenguer JOURNAL OF HEPATOLOGY
- Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus
- (2008) Christoph Welsch et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started